Back
Surgery Partners Stock Price Chart
Sponsored
SGRY
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
40
SGRY
Surgery Partners
Last Price:
21.83
Seasonality Move:
23.7%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SGRY is experiencing selling pressure, which indicates risk of future bearish movement.
Surgery Partners Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.1 | Sell |
20-day SMA: | 28.77 | Sell |
50-day SMA: | 30.39 | Sell |
200-day SMA: | 28.64 | Sell |
8-day EMA: | 25.82 | Sell |
20-day EMA: | 28.08 | Sell |
50-day EMA: | 29.43 | Sell |
200-day EMA: | 29.47 | Sell |
Surgery Partners Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.72 | Sell |
Relative Strength Index (14 RSI): | 22.28 | Sell |
Chaikin Money Flow: | -1703456 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.66 - 32.26) | Sell |
Bollinger Bands (100): | (26.79 - 32.25) | Sell |
Surgery Partners Technical Analysis
Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Surgery Partners Stock
Is Surgery Partners Stock a Buy?
- Surgery Partners share price is 21.83 while SGRY 8-day simple moving average is 27.10, which is a Sell signal.
- The stock price of SGRY is 21.83 while Surgery Partners 20-day SMA is 28.77, which makes it a Sell.
- Surgery Partners 50-day simple moving average is 30.39 while SGRY share price is 21.83, making it a Sell technically.
- SGRY stock price is 21.83 and Surgery Partners 200-day simple moving average is 28.64, creating a Sell signal.
SGRY Technical Analysis vs Fundamental Analysis
Sell
40
Surgery Partners (SGRY)
is a Sell
Is Surgery Partners a Buy or a Sell?
-
Surgery Partners stock is rated a Sell
The current Surgery Partners [SGRY] share price is $21.83. The Score for SGRY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Surgery Partners Stock Info
Market Cap:
2.77B
Price in USD:
21.83
Share Volume:
2.48M
Surgery Partners 52-Week Range
52-Week High:
36.92
52-Week Low:
21.54
Sell
40
Surgery Partners (SGRY)
is a Sell
Surgery Partners Share Price Forecast
-
What is the Surgery Partners stock price today?
The Surgery Partners stock price is 21.83 USD today. -
Will SGRY stock go up or go down?
Surgery Partners> share price is forecast to RISE/FALL based on technical indicators -
Is Surgery Partners overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Surgery Partners is overvalued.
Is Surgery Partners Stock a Buy?
- Surgery Partners share price is 21.83 while SGRY 8-day exponential moving average is 25.82, which is a Sell signal.
- The stock price of SGRY is 21.83 while Surgery Partners 20-day EMA is 28.08, which makes it a Sell.
- Surgery Partners 50-day exponential moving average is 29.43 while SGRY share price is 21.83, making it a Sell technically.
- SGRY stock price is 21.83 and Surgery Partners 200-day simple moving average is 29.47, creating a Sell signal.
Fundamental Analysis of Surgery Partners
Is Surgery Partners a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.18 per share.
Technical Analysis of Surgery Partners
Should I short Surgery Partners stock?
- SGRY Moving Average Covergence Divergence (MACD) indicator is -1.72, suggesting Surgery Partners is a Sell
- Surgery Partners Relative Strength Index (RSI) is 22.28, which suggest Surgery Partners is oversold
- The Bollinger Bands (25) for Surgery Partners is (26.66 - 32.26), which suggest Surgery Partners is a Sell
- The Bollinger Bands (100) for Surgery Partners is (26.79 - 32.25), which suggest Surgery Partners is a Sell
* Surgery Partners stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.